1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of CX3CR1 mRNA CTD PMID:28960355 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CX3CR1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CX3CR1 mRNA CTD PMID:26377647 , PMID:29673856 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine increases expression ISO RGD:1352124 6480464 Platelet Activating Factor results in increased expression of CX3CR1 mRNA CTD PMID:16386258 2-butoxyethanol decreases expression EXP 6480464 n-butoxyethanol results in decreased expression of CX3CR1 mRNA CTD PMID:19812364 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of CX3CR1 mRNA CTD PMID:20188158 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis4-hydroxyphenylsulfone results in increased expression of CX3CR1 mRNA CTD PMID:30951980 6-propyl-2-thiouracil decreases expression ISO RGD:620137 6480464 Propylthiouracil results in decreased expression of CX3CR1 mRNA CTD PMID:24780913 acetamide increases expression ISO RGD:620137 6480464 acetamide results in increased expression of CX3CR1 mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO RGD:620137 6480464 Aflatoxin B1 results in increased expression of CX3CR1 mRNA CTD PMID:25378103 aflatoxin B1 decreases expression ISO RGD:1352124 6480464 Aflatoxin B1 results in decreased expression of CX3CR1 mRNA CTD PMID:32234424 ammonium chloride affects expression ISO RGD:620137 6480464 Ammonium Chloride affects the expression of CX3CR1 mRNA CTD PMID:16483693 amphetamine decreases expression ISO RGD:620137 6480464 Amphetamine results in decreased expression of CX3CR1 mRNA CTD PMID:30779732 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of CX3CR1 mRNA CTD PMID:21569818 benzo[a]pyrene decreases expression ISO RGD:1352124 6480464 Benzoapyrene results in decreased expression of CX3CR1 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1352124 6480464 Benzoapyrene affects the methylation of CX3CR1 3' UTR, Benzoapyrene affects the methylation of CX3CR1 exon CTD PMID:27901495 benzo[b]fluoranthene affects expression EXP 6480464 benzobfluoranthene affects the expression of CX3CR1 mRNA CTD PMID:26377693 Benzo[ghi]perylene increases expression EXP 6480464 1, 12-benzoperylene results in increased expression of CX3CR1 mRNA CTD PMID:26377693 Benzo[k]fluoranthene increases expression EXP 6480464 benzokfluoranthene results in increased expression of CX3CR1 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of CX3CR1 mRNA CTD PMID:28085963 bisphenol A affects expression ISO RGD:620137 6480464 bisphenol A affects the expression of CX3CR1 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CX3CR1 mRNA CTD PMID:29248573 bisphenol A decreases expression ISO RGD:620137 6480464 bisphenol A results in decreased expression of CX3CR1 mRNA CTD PMID:30816183 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of CX3CR1 mRNA CTD PMID:30951980 buta-1,3-diene decreases expression EXP 6480464 1, 3-butadiene results in decreased expression of CX3CR1 mRNA CTD PMID:29038090 cadmium atom decreases expression ISO RGD:1352124 6480464 Cadmium results in decreased expression of CX3CR1 mRNA CTD PMID:24376830 cannabidiol decreases expression EXP 6480464 Cannabidiol results in decreased expression of CX3CR1 mRNA CTD PMID:21542829 carbon nanotube affects expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon analog results in decreased expression of CX3CR1 mRNA CTD PMID:25620056 ceric oxide affects expression ISO RGD:620137 6480464 ceric oxide affects the expression of CX3CR1 mRNA CTD PMID:29463257 choline affects expression ISO RGD:1352124 6480464 Choline affects the expression of CX3CR1 mRNA CTD PMID:17616785 choline multiple interactions EXP 6480464 [Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CX3CR1 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CX3CR1 mRNA CTD PMID:20938992 , PMID:23439872 crocidolite asbestos increases expression EXP 6480464 Asbestos, Crocidolite results in increased expression of CX3CR1 mRNA CTD PMID:29507420 cyclophosphamide increases expression ISO RGD:620137 6480464 Cyclophosphamide results in increased expression of CX3CR1 protein CTD PMID:16651033 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CX3CR1 mRNA CTD PMID:29950665 diazinon decreases expression ISO RGD:1352124 6480464 Diazinon results in decreased expression of CX3CR1 mRNA CTD PMID:24356939 dioxygen increases expression ISO RGD:1352124 6480464 Oxygen deficiency results in increased expression of CX3CR1 mRNA, Oxygen deficiency results in increased expression of CX3CR1 protein CTD PMID:17476338 dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of CX3CR1 mRNA CTD PMID:24205000 disodium selenite decreases expression ISO RGD:1352124 6480464 Sodium Selenite results in decreased expression of CX3CR1 mRNA CTD PMID:18175754 divanadium pentaoxide increases expression ISO RGD:1352124 6480464 vanadium pentoxide results in increased expression of CX3CR1 mRNA CTD PMID:17459161 doxorubicin decreases expression ISO RGD:1352124 6480464 Doxorubicin results in decreased expression of CX3CR1 mRNA CTD PMID:29803840 entinostat increases expression ISO RGD:1352124 6480464 entinostat results in increased expression of CX3CR1 mRNA CTD PMID:27188386 ethanol multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CX3CR1 mRNA CTD PMID:30517762 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CX3CR1 mRNA CTD PMID:30319688 ethanol affects expression EXP 6480464 Ethanol affects the expression of CX3CR1 mRNA CTD PMID:30319688 ferric oxide decreases expression EXP 6480464 ferric oxide analog results in decreased expression of CX3CR1 mRNA CTD PMID:25086211 folic acid multiple interactions EXP 6480464 [Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CX3CR1 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CX3CR1 mRNA CTD PMID:20938992 , PMID:23439872 gamma-hexachlorocyclohexane decreases expression ISO RGD:1352124 6480464 Hexachlorocyclohexane results in decreased expression of CX3CR1 mRNA CTD PMID:24356939 GW 501516 decreases expression ISO RGD:1352124 6480464 GW 501516 results in decreased expression of CX3CR1 mRNA CTD PMID:19850645 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CX3CR1 mRNA CTD PMID:20938992 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of CX3CR1 mRNA CTD PMID:21829687 lipopolysaccharide increases expression ISO RGD:620137 6480464 Lipopolysaccharides results in increased expression of CX3CR1 mRNA CTD PMID:21846543 mechlorethamine increases expression ISO RGD:620137 6480464 Mechlorethamine results in increased expression of CX3CR1 mRNA, Mechlorethamine results in increased expression of CX3CR1 protein CTD PMID:26273949 , PMID:28184907 mechlorethamine multiple interactions ISO RGD:620137 6480464 Valproic Acid inhibits the reaction [Mechlorethamine results in increased expression of CX3CR1 mRNA] CTD PMID:28184907 methamphetamine decreases expression ISO RGD:620137 6480464 Methamphetamine results in decreased expression of CX3CR1 mRNA CTD PMID:19564919 monosodium L-glutamate increases expression EXP 6480464 Sodium Glutamate results in increased expression of CX3CR1 mRNA CTD PMID:22078008 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression ISO RGD:1352124 6480464 N more ... CTD PMID:19013360 nickel atom decreases expression ISO RGD:1352124 6480464 Nickel results in decreased expression of CX3CR1 mRNA CTD PMID:23195993 nickel atom increases expression ISO RGD:1352124 6480464 Nickel results in increased expression of CX3CR1 mRNA CTD PMID:25583101 O-methyleugenol decreases expression ISO RGD:1352124 6480464 methyleugenol results in decreased expression of CX3CR1 mRNA CTD PMID:32234424 ochratoxin A increases expression ISO RGD:1352124 6480464 ochratoxin A metabolite results in increased expression of CX3CR1 mRNA, ochratoxin A results in increased expression of CX3CR1 mRNA CTD PMID:24356939 paracetamol multiple interactions EXP 6480464 [MST1R protein mutant form co-treated with Acetaminophen] results in increased expression of CX3CR1 mRNA CTD PMID:22575169 paracetamol increases expression ISO RGD:1352124 6480464 Acetaminophen results in increased expression of CX3CR1 mRNA CTD PMID:26690555 paraquat decreases response to substance EXP 6480464 CX3CR1 protein results in decreased susceptibility to Paraquat CTD PMID:23299473 paraquat multiple interactions EXP 6480464 [LRRK2 protein results in increased susceptibility to Paraquat] which results in decreased expression of CX3CR1 protein CTD PMID:31174552 pentane-2,3-dione increases expression ISO RGD:620137 6480464 2, 3-pentanedione results in increased expression of CX3CR1 mRNA CTD PMID:25710175 phenobarbital increases expression ISO RGD:1352124 6480464 Phenobarbital results in increased expression of CX3CR1 mRNA CTD PMID:19084549 quercetin multiple interactions EXP 6480464 Quercetin affects the reaction [CX3CR1 protein affects the activity of PTGS2 protein] more ... CTD PMID:20361964 silicon dioxide decreases expression ISO RGD:1352124 6480464 Silicon Dioxide analog results in decreased expression of CX3CR1 mRNA CTD PMID:25895662 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CX3CR1 mRNA CTD PMID:29341224 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of CX3CR1 mRNA CTD PMID:19073995 simvastatin decreases expression ISO RGD:1352124 6480464 Simvastatin results in decreased expression of CX3CR1 mRNA CTD PMID:18359719 sodium arsenite affects methylation ISO RGD:1352124 6480464 sodium arsenite affects the methylation of CX3CR1 gene CTD PMID:28589171 Soman increases expression ISO RGD:620137 6480464 Soman results in increased expression of CX3CR1 mRNA CTD PMID:19281266 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CX3CR1 mRNA CTD PMID:21641980 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CX3CR1 mRNA CTD PMID:23288052 tetrachloromethane multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CX3CR1 mRNA CTD PMID:30517762 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CX3CR1 mRNA CTD PMID:29950665 trichloroethene multiple interactions EXP 6480464 PPARA protein inhibits the reaction [Trichloroethylene results in decreased expression of CX3CR1 mRNA] CTD PMID:15363585 valproic acid increases methylation ISO RGD:1352124 6480464 Valproic Acid results in increased methylation of CX3CR1 gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:620137 6480464 Valproic Acid inhibits the reaction [Mechlorethamine results in increased expression of CX3CR1 mRNA] CTD PMID:28184907